Anortho-Quinodimethane Route to Lasofoxifene and U23469

Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis

(2011) Gregory M Peterson et al.   ANNALS OF PHARMACOTHERAPY

Lasofoxifene in osteoporosis and its place in therapy

(2010) Victoria J. D. Swan et al.   ADVANCES IN THERAPY

Facile access to boryltetralins and borylnaphthalenes via a cycloaddition using o-quinodimethanes

(2010) Hiroto Yoshida et al.   CHEMICAL COMMUNICATIONS

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women

(2010) A. Z. LaCroix et al.   JNCI-Journal of the National Cancer Institute

Synthesis of Lasofoxifene, Nafoxidine and Their Positional Isomers via the Novel Three-Component Coupling Reaction

(2010) Kenya Nakata et al.   MOLECULES

Lasofoxifene in Postmenopausal Women with Osteoporosis

(2010) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Palladium-Catalyzed [4 + 2] Cycloaddition ofo-(Silylmethyl)benzyl Esters with Ketones: An Equivalent to Oxo-Diels−Alder Reaction ofo-Xylylenes

(2010) Satoshi Ueno et al.   ORGANIC LETTERS

[4+2] Cycloaddition ofo-Xylylenes with Imines Using Palladium Catalyst

(2009) Satoshi Ueno et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Synthesis and dehydration reaction of 1-(4-benzyloxyphenyl)-6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphth-2-ol: possible intermediate of Lasofoxifene

(2009) Ludmila Hejtmánková et al.   RESEARCH ON CHEMICAL INTERMEDIATES

Palladium-Catalyzed Disilylation ofo-Quinodimethanes: Synthesis of 9- and 10-Membered Disilacarbocycles

(2008) Hiroto Yoshida et al.   ORGANIC LETTERS